Predictors of readmission after breast reconstruction: A multi-institutional analysis of 5012 patients

Annals of Plastic Surgery

Volumn 71, Issue 4, 2013, Pages 335-341

  Mlodinow, Alexei S ^a   Ver Halen, Jon P ^b   Lim, Seokchum ^c   Nguyen, Khang T ^a   Gaido, Jessica A ^a   Kim, John Y S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

30 day; Breast reconstruction; NSQIP; Outcomes; Readmissions

Indexed keywords

ADULT; BREAST AUGMENTATION; BREAST IMPLANT; BREAST NEOPLASMS; BREAST RECONSTRUCTION; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; DEVICES; EVALUATION STUDY; FACTUAL DATABASE; FEMALE; HOSPITAL READMISSION; HUMAN; MASTECTOMY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROCEDURES; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SURGICAL FLAPS; TISSUE EXPANDER; TRANSPLANTATION; TREATMENT OUTCOME; ARTICLE; BREAST TUMOR; EQUIPMENT; METHODOLOGY; POSTOPERATIVE COMPLICATION; STATISTICS;

ADULT; BREAST IMPLANTATION; BREAST IMPLANTS; BREAST NEOPLASMS; DATABASES, FACTUAL; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LOGISTIC MODELS; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL FLAPS; TISSUE EXPANSION DEVICES; TREATMENT OUTCOME;

EID: 84884703500     PISSN: 01487043     EISSN: 15363708     Source Type: Journal    
DOI: 10.1097/SAP.0b013e3182a0df25     Document Type: Article

References (56)

1. Wilkins EG, Cederna PS, Lowery JC, et al. Prospective analysis of psychosocial outcomes in breast reconstruction: One-year postoperative results from the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg. 2000;106:1014-1025; discussion 1026-1027
2. Atisha D, Alderman AK, Lowery JC, et al. Prospective analysis of long-term psychosocial outcomes in breast reconstruction: Two-year postoperative results from the Michigan Breast Reconstruction Outcomes Study. Ann Surg. 2008;247:1019-1028
3. TheWomen's Health and Cancer Rights Act. Available at: Http://www.cms.hhs.gov/ apps/statehipaalaws/content/whcra.asp. Accessed March 14, 2013
4. Alderman AK, Wei Y, Birkmeyer JD. Use of breast reconstruction after mastectomy following the Women's Health and Cancer Rights Act. JAMA. 2006;295: 387-388
5. Agarwal S, Pappas L, Neumayer L, et al. An analysis of immediate postmastectomy breast reconstruction frequency using the surveillance, epidemiology, and end results database. Breast J. 2011;17:352-358
6. Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. Breast reconstruction: Increasing implant rates. Plast Reconstr Surg. 2013;131:15-23
7. Rau J. Hospitals face pressure to avert readmissions. New York Times. November 26, 2012. http://www.nytimes.com/2012/11/27/health/hospitals- facepressure-from-medicare-to-avert-readmissions.html?-r=0
8. Readmissions Reduction Program. http://cms.gov/Medicare/Medicare-Fee-for- Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html/. Accessed January 5, 2013
9. Patient Protection and Affordable Care Act. Pub L No. 111-148
10. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-1428
11. Kocher RP, Adashi EY. Hospital readmissions and the Affordable Care Act: Paying for coordinated quality care. JAMA. 2011;306:1794-1795
12. Fontanarosa PB, McNutt RA. Revisiting hospital readmissions. JAMA. 2013;309:398-400
13. Dharmarajan K, Hseih AF, Lin Z, et al. Diagnosis and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013;309:355-363
14. Anderson GF, Steinberg EP. Hospital readmissions in the Medicare population. N Engl J Med. 1984;311:1349-1353
15. Khuri SF, Henderson WG, DePalma RG, et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242:326-341
16. Kassin MT, Owen RM, Perez SD, et al. Risk factors for 30-day hospital readmission among general surgery patients. JAmColl Surg. 2012;215:322-330
17. Olsen MA, Chu-Ongsakul S, Brandt KE, et al. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg. 2008;143:53-60
18. American College of Surgeons National Surgical Quality Improvement Program. Available at www.acsnsqip.org. Last Accessed January, 2013
19. American College of Surgeons. American College of Surgeons National Quality Improvement Program User Guide for the 2011 Participant Use File [NSQIP Online User Guide]. Available at: Http://site.acsnsqip.org/wp-content/ uploads/2012/03/2011-User-Guide-Final.pdf; Last Accessed March 10, 2013
20. Merkow RP, Bilimoria KY, Hall BL. Interpretation of the C-statistic in the context of ACS-NSQIP models. Ann Surg Oncol. 2011;18:S295; author reply S296
21. Cohen ME, Bilimoria KY, Ko CY, et al. Development of an American College of Surgeons National Surgery Quality Improvement Program: Morbidity and mortality risk calculator for colorectal surgery. J Am Coll Surg. 2009;208: 1009eY1016e.
22. Paul P, Pennell ML, Lemeshow S. Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets. Stat Med. 2013;32:67-80
23. Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203-5209
24. Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362-1367
25. Yao K, Stewart AK, Winchester DJ, et al. Trends in contralateral prophylactic mastectomy for unilateral cancer: A report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010;17:2554-2562
26. Habermann EB, Abbott A, Parsons HM, et al. Are mastectomy rates really increasing in the United States? J Clin Oncol. 2010;28:3437-3441
27. Cemal Y, Albornoz CR, Disa JJ, et al. A paradigm shift in U.S. Breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg. 2013;131:320eY326e.
28. Sellers MM, Merkow RP, Halverson A, et al. Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2013;216:420-427
29. Mioton LM, Smetona JT, Hanwright PJ, et al. A retrospective study comparing thirty-day morbidity outcomes in prosthetic and autologous tissue breast reconstruction: A multivariate analysis of 13,082 patients. J Plast Reconstr Aesthet Surg. 2013;66:917-925
30. Pinsolle V, Grinfeder C, Mathoulin-Pelissier S, et al. Complications analysis of 266 immediate breast reconstructions. J Plast Reconstr Aesthet Surg. 2006; 59:1017-1024
31. Nahabedian MY, Momen B, Manson PN. Factors associated with anastomotic failure after microvascular reconstruction of the breast. Plast Reconstr Surg. 2004;114:74-82
32. Morris DS, Rohrbach J, Rogers M, et al. The surgical revolving door: Risk factors for hospital readmission. J Surg Res. 2011;170:297-301
33. Price JD, Romeiser JL, Gnerre JM, et al. Risk analysis for readmission after coronary artery bypass surgery: Developing a strategy to reduce readmissions. J Am Coll Surg. 2013;216:412-419
34. Schneider EB, Hyder O, Brooke BS, et al. Patient readmission and mortality after colorectal surgery for colon cancer: Impact of length of stay relative to other clinical factors. J Am Coll Surg. 2012;214:390-398
35. Gart MS, Smetona JT, Hanwright PJ, et al. Autologous options for postmastectomy breast reconstruction: A comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2013;216:229-238
36. Leyngold MM, Stutman RL, Khiabani KT, et al. Contributing variables to post mastectomy tissue expander infection. Breast J. 2012;18:351-356
37. Wolters U,Wolf T, Stutzer H, et al. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth. 1996;77:217-222
38. Saha S, Davila AA, Ver Halen J, et al. A comparison of patients with and without reconstructive mastectomy: An analysis of outcomes. Manuscript in submission
39. Mioton LM, Buck DW, Rambachan A, et al. Predictors of readmission after outpatient plastic surgery. Manuscript in submission
40. Tan TW, Kalish JA, Hamburg NM, et al. Shorter duration of femoral-popliteal bypass is associated with decreased surgical site infection and shorter hospital length of stay. J Am Coll Surg. 2012;215:512-518
41. Hanwright PJ, Davila A, Mioton LM, et al. A predictive model of risk and outcomes in tissue expander reconstruction: A multivariate analysis of 9,786 patients. J Plast Surg Hand Surg. 2013. In press
42. Surgical Care Improvement Project National Hospital Inpatient Quality Measures. Available at: Http://www.qualitynet.org/dcs/ContentServer?c= Page&pagename= QnetPublic%2FPage%2FQnetTier4&cid=1228767363466. Last accessed April 7, 2013
43. Fischer J-P, Cleveland E-C, Nelson J-A, et al. Breast reconstruction in the morbidly obese patientVassessment of 30-day morbidity using the 2005-2010 National Surgical Quality Improvement Program (NSQIP) Datasets. In press
44. Peled AW, Stover AC, Foster RD, et al. Long-term reconstructive outcomes after expander-implant breast reconstruction with serious infectious or woundhealing complications. Ann Plast Surg. 2012;68:369-373
45. Lin KY, Johns FR, Gibson J, et al. An outcome study of breast reconstruction: Presurgical identification of risk factors for complications. Ann Surg Oncol. 2001;8:586-591
46. Padubidri AN, Yetman R, Browne E, et al. Complications of postmastectomy breast reconstructions in smokers, ex-smokers, and nonsmokers. Plast Reconstr Surg. 2001;107:342-349; discussion 350-1
47. McCarthy CM, Mehrara BJ, Riedel E, et al. Predicting complications following expander/implant breast reconstruction: An outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg. 2008;121:1886-1892
48. Davila AA, Seth AK, Wang E, et al. Human acellular dermis versus submuscular tissue expander breast reconstruction: A multivariate comparative analysis of short-term complications based on the National Surgical Quality ]Improvement Program (NSQIP) Database. Arch Plast Surg. 2013;40:19-27
49. Hensel JM, Lehman JA Jr, Tantri MP, et al. An outcomes analysis and satisfaction survey of 199 consecutive abdominoplasties. Ann Plast Surg. 2001; 46:357-363
50. Fisher JP, Siever B, Nelson JA, et al. Comprehensive outcomes and cost analysis of free tissue transfer for breast reconstruction: An experience with 1303 flaps. Plast Reconstr Surg. 2013;131:195-203
51. Gill PS, Hunt JP, Guerra AB, et al. A 10-year retrospective review of 758 DIEP flaps for breast reconstruction. Plast Reconstr Surg. 2004;113:1153-1160
52. Hanwright PJ, Davila AA, Hirsch EM, et al. The differential effect of BMI on prosthetic versus autogenous breast reconstruction: A multivariate analysis of 12,986 patients. Breast. 2013. In press
53. Davila AA, Mioton LM, Chow G, et al. Immediate two-stage tissue expander breast reconstruction versus one-stage permanent implant breast reconstruction: A multi-institutional comparison of short-term complications. J Plast Surg Hand Surg. 2013. In press
54. Kroll SS, Schusterman MA, Reece GP, et al. Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg. 1996;98: 1230-1233
55. Nahabedian MY, Tsangaris T, Momen B, et al. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg. 2003;112:467-476
56. Christian CK, Niland J, Edge SB, et al. A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: A study of the National Comprehensive Cancer Network. Ann Surg. 2006;243:241-249